CME GROUP INC. Debt Disclosure
| (in millions) | 2025 | 2024 | ||||||||||||
$750.0 million fixed rate notes due March 2025, stated rate of 3.00% (1) | $ | — | $ | 749.8 | ||||||||||
| Total short-term debt | $ | — | $ | 749.8 | ||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
$500.0 million fixed rate notes due June 2028, stated rate of 3.75% | $ | 498.9 | $ | 498.5 | ||||||||||
| $750.0 million fixed rate notes due March 2030, stated rate of 4.4% | 742.1 | — | ||||||||||||
| $750.0 million fixed rate notes due March 2032, stated rate of 2.65% | 744.6 | 743.7 | ||||||||||||
$750.0 million fixed rate notes due September 2043, stated rate of 5.30% (1) | 744.6 | 744.3 | ||||||||||||
$700.0 million fixed rate notes due June 2048, stated rate of 4.15% | 692.1 | 691.7 | ||||||||||||
| Total long-term debt | $ | 3,422.3 | $ | 2,678.2 | ||||||||||
| (in millions) | Par Value | ||||
| 2026 | $ | — | |||
| 2027 | — | ||||
| 2028 | 500.0 | ||||
| 2029 | — | ||||
| 2030 | 750.0 | ||||
| Thereafter | 2,200.0 | ||||
Want the next CME GROUP INC. debt disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment CME GROUP INC.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 27, 2023 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Feb 26, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Mar 1, 2018 | |
| 2016 | Feb 27, 2017 | |
| 2015 | Feb 26, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.